Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Dana Busschots"'
Autor:
Dana Busschots, Cécile Kremer, Rob Bielen, Özgür M. Koc, Leen Heyens, Frederik Nevens, Niel Hens, Geert Robaeys
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background The introduction of highly effective direct-acting antiviral therapy has changed the hepatitis C virus (HCV) treatment paradigm. However, a recent update on HCV epidemiology in incarcerated settings is necessary to accurately dete
Externí odkaz:
https://doaj.org/article/d00af9b17248451eb8de15ccb95939e3
Autor:
Kasper T. Christensen, Florian Pierard, David Bonsall, Rory Bowden, Eleanor Barnes, Eric Florence, M. Azim Ansari, Dung Nguyen, Mariateresa de Cesare, Frederik Nevens, Geert Robaeys, Yoeri Schrooten, Dana Busschots, Peter Simmonds, Anne-Mieke Vandamme, Eric Van Wijngaerden, Tim Dierckx, Lize Cuypers, Kristel Van Laethem
Publikováno v:
Viruses, Vol 15, Iss 12, p 2391 (2023)
The hepatitis C virus (HCV) epidemic in Western countries is primarily perpetuated by the sub-populations of men who have sex with men (MSM) and people who inject drugs (PWID). Understanding the dynamics of transmission in these communities is crucia
Externí odkaz:
https://doaj.org/article/68065b242c224395bd35e6aa2784fa34
Autor:
Dana Busschots, Erwin Ho, Sarah Blach, Frederik Nevens, Homie Razavi, Brieuc Van Damme, Thomas Vanwolleghem, Geert Robaeys
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Chronic infection with the hepatitis C virus (HCV) remains a worldwide health problem. As a result, the World Health Organization (WHO) has set elimination targets by 2030. This study aims to examine the position of Belgium in mee
Externí odkaz:
https://doaj.org/article/dd9fd1efdfe349c5b9c33b92f7a5c0c7
Autor:
Dana Busschots, Rob Bielen, Özgür M. Koc, Leen Heyens, Rita Verrando, Chantal de Galocsy, Christophe Van Steenkiste, Frederik Nevens, Håvard Midgard, Olav Dalgard, Geert Robaeys
Publikováno v:
Harm Reduction Journal, Vol 18, Iss 1, Pp 1-7 (2021)
Abstract Background There is currently no systematic screening for hepatitis C (HCV) reinfection in people who inject drugs (PWID) after treatment in Belgium. However, in a recent meta-analysis, the overall HCV reinfection rate was 5.9/100 person-yea
Externí odkaz:
https://doaj.org/article/ad1ade97a4e844a2bc86226831582fcc
Autor:
Dana Busschots, Rob Bielen, Özgür M. Koc, Leen Heyens, Eefje Dercon, Rita Verrando, Filip Janssens, Luc Van den Bergh, Peter Van Lint, Liesbeth Bruckers, Frederik Nevens, Geert Robaeys
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Screening and treatment of hepatitis C virus (HCV) infection in people who use drugs (PWUD) remains insufficient. Reducing the burden of HCV infection in PWUD requires interventions focusing on the different steps of the HCV care
Externí odkaz:
https://doaj.org/article/d6ee85deaf2a428aa320c3bd4dcd6557
Autor:
Dana Busschots, Cécile Kremer, Rob Bielen, Özgür M. Koc, Leen Heyens, Christian Brixko, Pierre Laukens, Hans Orlent, Pascal Bilaey, Francis De Smet, Geert Hellemans, Gaetan Muyldermans, Luk Van Baelen, Niel Hens, Hans Van Vlierberghe, Geert Robaeys
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Prevalence data on viral hepatitis B (HBV), hepatitis C (HCV), and HIV infection in prison are often scarce or outdated. There is currently no systematic screening for these blood-borne viral infections (BBV) in Belgian prisons. T
Externí odkaz:
https://doaj.org/article/7b9a3a4fc18d4eb886cc50c8bc8f9ffe
Autor:
Dana Busschots, Cécile Kremer, Rob Bielen, Özgür Muhammet Koc, Leen Heyens, Eefje Dercon, Rita Verrando, Tessa Windelinckx, Griet Maertens, Stefan Bourgeois, Niel Hens, Catharina Matheï, Geert Robaeys
Publikováno v:
Harm Reduction Journal, Vol 18, Iss 1, Pp 1-9 (2021)
Abstract Background Targeted screening for hepatitis C viral (HCV) infection is not yet widely executed in Belgium. When performed in people who use drugs (PWUD), it is mainly focused on those receiving opiate agonist therapy (OAT). We wanted to reac
Externí odkaz:
https://doaj.org/article/262fb461a600431c92c4c4d63822c80b
Autor:
Dana Busschots, Cécile Kremer, Özgür M. Koc, Leen Heyens, Rob Bielen, Ludwig Apers, Eric Florence, Peter Messiaen, Kristel Van Laethem, Eric Van Wijngaerden, Frederik Nevens, Niel Hens, Geert Robaeys
Publikováno v:
International Journal of Infectious Diseases, Vol 105, Iss , Pp 217-223 (2021)
Objectives: The Belgian population of people living with HIV (PLHIV) has unrestricted access to direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) infection, since 2017. International literature claims that half of the patients remai
Externí odkaz:
https://doaj.org/article/e1c56337b4c24a6d831d00da9064e761
Autor:
Dana Busschots, Samira Toghanian, Rob Bielen, Stina Salomonsson, Özgür M. Koc, Greet Hendrickx, Michel Jadoul, Frederik Nevens, Etienne Sokal, Christian Brixko, Kathelijne Peerlinck, Ludwig Apers, Geert Robaeys, Jeffrey V. Lazarus
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Hepatitis C virus is one of the leading causes of chronic liver disease and liver-related deaths worldwide. The estimated prevalence of chronic hepatitis C viral infection among the general Belgian population was 0.57% (n = 64,000
Externí odkaz:
https://doaj.org/article/7380e736e7a54be8ab08c51d4094a3f0
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver disease (NAFLD) worldwide. NAFLD comprises different stadia going from isolated steatosis to non-alcoholic steatohepatitis (NASH). NASH is a chronic state of
Externí odkaz:
https://doaj.org/article/e107b03775f644a9a51aaacd6ef3c578